Početna › Rak dojke › Oklahoma
Kliničke studije za Rak dojke u državi Oklahoma
20 studija za Rak dojke traži sudionike na lokacijama u državi Oklahoma.
Gradovi u državi Oklahoma
Službeni tekst studije (engleski)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Oklahoma, Oklahoma City
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- Oklahoma Proton Center, Oklahoma City
U tijeku regrutacijaFaza 2
Od 50 godina i više · Žene · Ažurirano 29. ruj 2026. · NCT01766297Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Oklahoma City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05867251Biopsy-site-marker in Breast Cancer
- OU Health Stephenson Cancer Center, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Žene · Ažurirano 22. ruj 2026. · NCT07833566A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Oklahoma Cancer Specialists and Research Institute (OCSRI) - Tulsa Cancer Center, Tulsa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT06492616A Phase 1/1b Study of IAM1363 in HER2 Cancers
- OU Health Stephenson Cancer Center, Oklahoma City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06253871The Vanguard Study: Testing a New Way to Screen for Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 45 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT06995898Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Žene · Ažurirano 2. ruj 2026. · NCT05879926Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06500481Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Oklahoma - Health Sciences Center, Oklahoma City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT05579366E-Mindfulness Approaches for Living After Breast Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 50 godina · Oba spola · Ažurirano 4. kol 2026. · NCT06748222A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Stephenson Cancer Center Oklahoma University Health, Oklahoma City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT05377996De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaFaza 3
Od 50 do 70 godina · Oba spola · Ažurirano 23. tra 2026. · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. ožu 2026. · NCT06418204Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
- Stephenson Cancer Center, Oklahoma City
- Stephenson Cancer Center- Tulsa, Tulsa
U tijeku regrutacijaRana faza 1
Od 18 do 99 godina · Oba spola · Ažurirano 26. sij 2026. · NCT05921253Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
- OU Health Stephenson Cancer Center, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT07014618SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Exelixis Clinical Site #13, Oklahoma City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 5. ruj 2025. · NCT05932862BostonGene and Exigent Genomic INsight Study
- Oklahoma Cancer Specialists and Research Institute, Tulsa
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. velj 2025. · NCT06272864Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.